Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04374968 · ClinicalTrials.gov registry record · NA

Use of Blood Flow Restriction Therapy Following ACL Tear

A NA study of Knee Injuries and Anterior Cruciate Ligament Tear, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04374968 is a NA study of Knee Injuries and Anterior Cruciate Ligament Tear that has completed, run by Henry Ford Health System. The registered enrollment target is 50 participants, below the 175-participant average among 14 other Knee Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04374968, a NA study of Knee Injuries and Anterior Cruciate Ligament Tear, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear

Interventions

  • DEVICE Blood flood restriction cuff

Study Locations (1)

Michigan

  • Henry Ford Hospital - West Bloomfield

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-07-28
Est. Completion 2022-05-01
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT04374968

The ClinicalTrials.gov registry entry for NCT04374968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 175-participant average among 14 other Knee Injuries trials with a reported enrollment target (71% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Knee Injuries appearing as the primary indexed condition, and to 1 intervention - of which Blood flood restriction cuff is the first listed.

NCT04374968 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04374968 about?

NCT04374968 is a clinical study titled "Use of Blood Flow Restriction Therapy Following ACL Tear". Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear

What is the current status of trial NCT04374968?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-07-28. Estimated completion is 2022-05-01.

What conditions does trial NCT04374968 study?

This clinical trial studies the following conditions: Knee Injuries, Anterior Cruciate Ligament Tear, Sport Injury.

What interventions are being tested in trial NCT04374968?

The interventions under investigation include: Blood flood restriction cuff (DEVICE).

Who is sponsoring clinical trial NCT04374968?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04374968 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.